| Vickie L Massey, MD | |
|
12200 W 110th St, Overland Park, KS 66210-4045 | |
| (913) 574-2650 | |
| (913) 574-2769 |
| Full Name | Vickie L Massey |
|---|---|
| Gender | Female |
| Speciality | Radiation Oncology |
| Experience | 39 Years |
| Location | 12200 W 110th St, Overland Park, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326019035 | NPI | - | NPPES |
| 100125440T | Medicaid | KS | |
| 1326019035 | Medicaid | MO | |
| 100125440L | Medicaid | KS | |
| 100125440M | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | R1P32 (Missouri) | Secondary |
| 2085R0001X | Radiology - Radiation Oncology | 04-26297 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Research Medical Center | Kansas city, MO | Hospital |
| Belton Regional Medical Center | Belton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Oncology Associates Llc | 3779635172 | 57 |
| Midwest Oncology Associates Llc | 3779635172 | 57 |
News Archive
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) on the new drug application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for relapsing-remitting multiple sclerosis (MS).
Organoids are bits of tissue grown in vitro, in a near-physiological 3D setting. The particularity consists in the fact that organoids retain features of the patient they are derived from, even when cultured outside of the human body. This is very different from what traditional, conventional cell culture has been able to do over the past 50 years or so.
Adverse events from antibiotics cause an estimated 142,000 emergency department visits per year in the United States, according to a study published in the September 15, 2008 issue of Clinical Infectious Diseases.
Patterson Companies, Inc. today reported consolidated sales of $883,819,000 for the fourth quarter of fiscal 2011 ended April 30, an increase of 9% from $812,762,000 in the year-earlier quarter.
› Verified 1 days ago
| Entity Name | Midwest Oncology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699911677 PECOS PAC ID: 3779635172 Enrollment ID: O20090716000071 |
News Archive
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) on the new drug application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for relapsing-remitting multiple sclerosis (MS).
Organoids are bits of tissue grown in vitro, in a near-physiological 3D setting. The particularity consists in the fact that organoids retain features of the patient they are derived from, even when cultured outside of the human body. This is very different from what traditional, conventional cell culture has been able to do over the past 50 years or so.
Adverse events from antibiotics cause an estimated 142,000 emergency department visits per year in the United States, according to a study published in the September 15, 2008 issue of Clinical Infectious Diseases.
Patterson Companies, Inc. today reported consolidated sales of $883,819,000 for the fourth quarter of fiscal 2011 ended April 30, an increase of 9% from $812,762,000 in the year-earlier quarter.
› Verified 1 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922144856 PECOS PAC ID: 8921911587 Enrollment ID: O20101228000020 |
News Archive
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) on the new drug application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for relapsing-remitting multiple sclerosis (MS).
Organoids are bits of tissue grown in vitro, in a near-physiological 3D setting. The particularity consists in the fact that organoids retain features of the patient they are derived from, even when cultured outside of the human body. This is very different from what traditional, conventional cell culture has been able to do over the past 50 years or so.
Adverse events from antibiotics cause an estimated 142,000 emergency department visits per year in the United States, according to a study published in the September 15, 2008 issue of Clinical Infectious Diseases.
Patterson Companies, Inc. today reported consolidated sales of $883,819,000 for the fourth quarter of fiscal 2011 ended April 30, an increase of 9% from $812,762,000 in the year-earlier quarter.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vickie L Massey, MD Po Box 411851, Kansas City, MO 64141-1851 Ph: (913) 574-2800 | Vickie L Massey, MD 12200 W 110th St, Overland Park, KS 66210-4045 Ph: (913) 574-2650 |
News Archive
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) on the new drug application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for relapsing-remitting multiple sclerosis (MS).
Organoids are bits of tissue grown in vitro, in a near-physiological 3D setting. The particularity consists in the fact that organoids retain features of the patient they are derived from, even when cultured outside of the human body. This is very different from what traditional, conventional cell culture has been able to do over the past 50 years or so.
Adverse events from antibiotics cause an estimated 142,000 emergency department visits per year in the United States, according to a study published in the September 15, 2008 issue of Clinical Infectious Diseases.
Patterson Companies, Inc. today reported consolidated sales of $883,819,000 for the fourth quarter of fiscal 2011 ended April 30, an increase of 9% from $812,762,000 in the year-earlier quarter.
› Verified 1 days ago
Dr. Michael Farber, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 6650 W 110th St Ste 100, Overland Park, KS 66211 Phone: 913-344-9989 Fax: 913-344-9957 | |
Dr. Jeffrey Ralph Conaway, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5721 W 119th St, Overland Park, KS 66209 Phone: 913-498-7363 Fax: 913-498-6699 | |
Dr. Chad M Ruble, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8000 W 110th St, Suite 150, Overland Park, KS 66210 Phone: 913-599-6777 Fax: 913-599-3955 | |
Kimberly Wherry-roys, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Overland Park, KS 66204 Phone: 913-676-2310 | |
Dr. Susanne Marie Chow, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5721 W 119th St, Overland Park, KS 66209 Phone: 913-498-7164 Fax: 913-498-7899 | |
Dr. Michael A Hughes, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5721 W 119th St, Overland Park, KS 66209 Phone: 913-498-7409 Fax: 913-498-7470 | |
Samuel Joseph Hund, Radiology Medicare: Accepting Medicare Assignments Practice Location: 6650 W 110th St Ste 200, Overland Park, KS 66211 Phone: 913-319-8400 |